124 related articles for article (PubMed ID: 23260855)
1. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Kallio S; Puurunen J; Ruokonen A; Vaskivuo T; Piltonen T; Tapanainen JS
Fertil Steril; 2013 Apr; 99(5):1305-10. PubMed ID: 23260855
[TBL] [Abstract][Full Text] [Related]
2. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
3. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.
Arbo E; Vetori DV; Jimenez MF; Freitas FM; Lemos N; Cunha-Filho JS
Hum Reprod; 2007 Dec; 22(12):3192-6. PubMed ID: 17981819
[TBL] [Abstract][Full Text] [Related]
5. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
[TBL] [Abstract][Full Text] [Related]
6. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
7. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
9. Effect of laparoscopic excision of endometriomas on ovarian reserve: serial changes in the serum antimüllerian hormone levels.
Celik HG; Dogan E; Okyay E; Ulukus C; Saatli B; Uysal S; Koyuncuoglu M
Fertil Steril; 2012 Jun; 97(6):1472-8. PubMed ID: 22521696
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
Gassen DT; Herter LD; Chagas JK; Schmid H
Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
[TBL] [Abstract][Full Text] [Related]
11. Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
Roumen FJ; Dieben TO
Fertil Steril; 2006 Jan; 85(1):57-62. PubMed ID: 16412731
[TBL] [Abstract][Full Text] [Related]
12. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
14. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
15. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.
Streuli I; Fraisse T; Pillet C; Ibecheole V; Bischof P; de Ziegler D
Fertil Steril; 2008 Aug; 90(2):395-400. PubMed ID: 17919608
[TBL] [Abstract][Full Text] [Related]
16. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
[TBL] [Abstract][Full Text] [Related]
17. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
19. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
[TBL] [Abstract][Full Text] [Related]
20. Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Barreiros FA; Guazzelli CA; Barbosa R; Torloni MR; Barbieri M; Araujo FF
Contraception; 2011 Aug; 84(2):155-9. PubMed ID: 21757057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
